Oseltamivir Phosphate
- Product NDC
- 68071-2528
- 11-digit product format
- 680712528
- Labeler code
- 68071
- Product ID
- 68071-2528_d163f22e-4767-7042-e053-2a95a90a1528
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oseltamivir Phosphate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA209438
- Marketing category
- ANDA
- Marketing start
- 2018-02-23
- Marketing end
- 0000-00-00
- Substance
- OSELTAMIVIR PHOSPHATE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68071-2528 | I | Inactivated by FDA | 2026-08-03 | ||
| excluded package | package | 68071-2528 | 68071-2528-1 | I | Inactivated by FDA | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 68071-2528-1 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68071-2528-1 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68071-2528-1 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68071-2528-1 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68071-2528-1 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68071-2528-1 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68071-2528-1 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68071-2528-1 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68071-2528-1 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 68071-2528-1 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 68071-2528-1 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 68071-2528-1 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 68071-2528-1 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 68071-2528-1 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 68071-2528-1 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209438-001 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | |
| A209438-002 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | |
| A209438-003 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209438-001 | AB |
| A209438-002 | AB |
| A209438-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209438-002 | OSELTAMIVIR PHOSPHATE | EQ 45MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209438-003 | OSELTAMIVIR PHOSPHATE | EQ 75MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209438-001 | OSELTAMIVIR PHOSPHATE | EQ 30MG BASE | CAPSULE / ORAL | AB | 2018-02-23 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209438-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209438-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209438-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209438-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209438-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209438-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209438-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209438-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209438-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209438-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209438-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209438-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209438-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209438-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209438-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209438-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209438-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209438-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209438-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209438-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209438-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209438-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209438-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209438-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209438-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209438-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209438-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209438-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209438-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209438-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209438-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209438-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209438-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209438-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209438-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209438-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209438-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209438-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209438-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209438-001 | AB | 1 | 8072bd15b7f6… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6022fcc-885e-41f7-971c-fe19ade5d9ba | Product name | 9 | 20190926 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-2528-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-e87a-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use OSELTAMIVIR PHOSPHATE CAPSULES safely and effectively. See full prescribing information for OSELTAMIVIR PHOSPHATE CAPSULES. OSELTAMIVIR PHOSPHATE capsules, for oral use Initial U.S. Approval: 1999 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2528-1 | Oseltamivir Phosphate | 10 in 1 CARTON | CAPSULE | 10 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2528 | OSELTAMIVIR PHOSPHATE CAPSULE [NUCARE PHARMACEUTICALS,INC.] | 2 | Legacy NDC, 1 package rows | 20211130_caf3f373-218d-1940-e053-2995a90a23a0.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Sportpharm LLC | a8a40f98-f6bd-4ef0-af03-93ed0f473c10 | 2026-04-24 | Warnings, Adverse reactions | 209438 ANDA209438 |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | REMEDYREPACK INC. | ad90fe42-8d52-403e-9b07-b8536fbf335a | 2026-03-13 | Warnings, Adverse reactions | 209438 ANDA209438 |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | a0f71ac9-136c-4c8d-b30d-b8d08767c206 | 2023-11-16 | Warnings, Adverse reactions | 209438 ANDA209438 |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 8e81aaa7-7c40-4b05-b19a-cc70edd1d9f9 | 2023-11-01 | Warnings, Adverse reactions | 209438 ANDA209438 |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Asclemed USA, Inc. | 00be0870-2ebb-46e3-9e98-a8f068ec664a | 2022-09-22 | Warnings, Adverse reactions | 209438 ANDA209438 |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 1f754ad7-9df0-4121-8051-0a09491be3c7 | 2022-09-01 | Warnings, Adverse reactions | 209438 ANDA209438 |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 8d264c73-4dd9-4f7c-8a18-f31195cdd013 | 2022-08-01 | Warnings, Adverse reactions | 209438 ANDA209438 |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Camber Pharmaceuticals, Inc. | 2a673aa2-e8f0-4aa4-8782-6fb3067ff108 | 2018-03-07 | Warnings, Adverse reactions | 209438 ANDA209438 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312122 | oseltamivir phosphate 75 MG Oral Capsule | PSN | caf3f373-218d-1940-e053-2995a90a23a0 | 2 |
| 312122 | oseltamivir 75 MG Oral Capsule | SCD | caf3f373-218d-1940-e053-2995a90a23a0 | 2 |
| 312122 | oseltamivir (as oseltamivir phosphate) 75 MG Oral Capsule | SY | caf3f373-218d-1940-e053-2995a90a23a0 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-2528-1 | 68071252801 | 10 CAPSULE in 1 CARTON (68071-2528-1) | 10 capsule | 2021-09-01 | 0000-00-00 | No | No | Current |